Pro-apoptotic protein kinase Cδ is associated with intranuclear inclusions in a transgenic model of Huntington's disease

被引:20
|
作者
Zemskov, EA [1 ]
Jana, NR [1 ]
Kurosawa, M [1 ]
Miyazaki, H [1 ]
Sakamoto, N [1 ]
Nekooki, M [1 ]
Nukina, N [1 ]
机构
[1] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan
关键词
apoptosis; huntingtin; Huntington's disease; polyglutamine; protein kinase C; protein kinase C delta;
D O I
10.1046/j.1471-4159.2003.02002.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to investigate any effect of truncated mutant huntingtin (tNhtt) aggregation on protein kinase C (PKC) signaling in Huntington's disease (HD), we studied a possible association of PKC isoforms with the aggregates using cellular and transgenic models of HD. In this report we describe an association of mutant tNhtt with at least three PKC isoforms (alpha, delta, zeta), as revealed by co-immunoprecipitation assays and immunocytochemistry in a cellular model of HD (Neuro2a cells expressing tNhtt-150Q-EGFP), as well as a specific association of PKCdelta with intranuclear aggregates in a transgenic model (R6/2 mice). Immunoblot analysis of isolated nuclear fractions shows an elevation of nuclear PKCdelta in transgenic brain tissue. The observed elevation has a strong similarity with the apoptotic translocation of PKCdelta detected in experiments with the mouse neuroblastoma Neuro2a cells. Using a Neuro2a cell line expressing tNhtt with the nuclear localization signal, we demonstrate the association of PKCdelta with intranuclear aggregates and present evidence that accumulation of PKCdelta in cell nuclei does not depend on mutant htt nuclear translocation. Our results suggest that the association of PKCdelta with intranuclear htt-aggregates may affect its apoptotic function in a transgenic model of HD.
引用
收藏
页码:395 / 406
页数:12
相关论文
共 50 条
  • [11] Metformin therapy in a transgenic mouse model of Huntington's disease
    Ma, Thong C.
    Buescher, Jessica L.
    Oatis, Benjamin
    Funk, Jason A.
    Nash, Andrew J.
    Carrier, Raeann L.
    Hoyt, Kari R.
    NEUROSCIENCE LETTERS, 2007, 411 (02) : 98 - 103
  • [12] Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease
    Yang, Weiqi
    Xie, Jingmo
    Qiang, Qiang
    Li, Li
    Lin, Xiang
    Ren, Yiqing
    Ren, Wenlei
    Liu, Qiong
    Zhou, Guomin
    Wei, Wenshi
    Saiyin, Hexige
    Ma, Lixiang
    NEUROSCIENCE BULLETIN, 2019, 35 (06) : 1024 - 1034
  • [13] Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease
    Wu, Bor-Tsang
    Chiang, Ming-Chang
    Tasi, Ching-Yi
    Kuo, Chia-Hua
    Shyu, Woei-Cherng
    Kao, Chung-Lan
    Huang, Chih-Yang
    Lee, Shin-Da
    CARDIOVASCULAR TOXICOLOGY, 2016, 16 (02) : 111 - 121
  • [14] Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington’s Disease
    Bor-Tsang Wu
    Ming-Chang Chiang
    Ching-Yi Tasi
    Chia-Hua Kuo
    Woei-Cherng Shyu
    Chung-Lan Kao
    Chih-Yang Huang
    Shin-Da Lee
    Cardiovascular Toxicology, 2016, 16 : 111 - 121
  • [15] Behaviour changes in a transgenic model of Huntington's disease
    Klivenyi, P
    Bende, Z
    Hartai, Z
    Penke, Z
    Nemeth, H
    Toldi, J
    Vecsei, L
    BEHAVIOURAL BRAIN RESEARCH, 2006, 169 (01) : 137 - 141
  • [16] Protein aggregation and neurodegeneration: Clues from a yeast model of Huntington's disease
    Bocharova, N.
    Chave-Cox, R.
    Sokolov, S.
    Knorre, D.
    Severin, F.
    BIOCHEMISTRY-MOSCOW, 2009, 74 (02) : 231 - 234
  • [17] Metabolic deregulation associated with aging modulates protein aggregation in the yeast model of Huntington's disease
    Pradhan, Sai Sanwid
    Swaroop, R. Sai
    Kanikaram, Sai Phalguna
    Darshan, V. M. Datta
    Pargaonkar, Ashish
    Dandamudi, Rajesh Babu
    Sivaramakrishnan, Venketesh
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (19): : 10521 - 10538
  • [18] Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease
    Fan, Mannie M. Y.
    Fernandes, Herman B.
    Zhang, Lily Y. J.
    Hayden, Michael R.
    Raymond, Lynn A.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (14): : 3768 - 3779
  • [19] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Chen, Xi
    Wu, Jun
    Lvovskaya, Svetlana
    Herndon, Emily
    Supnet, Charlene
    Bezprozvanny, Ilya
    MOLECULAR NEURODEGENERATION, 2011, 6
  • [20] Progress in developing transgenic monkey model for Huntington’s disease
    Brooke R. Snyder
    Anthony W. S. Chan
    Journal of Neural Transmission, 2018, 125 : 401 - 417